Health Catalyst, Inc.

HCATNASDAQHealthcare● Active

$1.75

$-0.19(-9.59%)

Market Cap$128945030

P/E Ratio—

52W High$4.291

52W Low$0.955

Avg Volume666K

Open$1.93

Beta1.66

Free Cash Flow Financials Revenue

Health Catalyst, Inc. (HCAT) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

HCAT · free cash flow · updated Jun 8, 2026

Core FCF metrics

HCAT · FCF · TTM · margin & CAGR

Free cash flow was −$237,000 for FY2025 (fiscal year ending 2025-12-31), up 87.1% year-over-year The FCF margin was -0.1%.

FY2025 Free Cash Flow−$237,000▲ +87.1% YoY

Trailing 12M (TTM)$9.2MTrailing 4Q sum · TTM positive vs latest FY negative

FCF Margin-0.1%−$237,000 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

HCAT · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$731,000(1M)−$237,000▲ +87.1%-0.1%

FY2024$14.6M(16M)−$1.8M▲ +96.1%-0.6%

FY2023−$33.1M(14M)−$47.4M▲ +10.0%-16.0%

FY2022−$35.3M(17M)−$52.7M▼ 26.7%-19.1%

FY2021−$23.1M(18M)−$41.6M▼ 13.6%-17.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

HCAT · P/FCF · FCF yield · FCF per share

Health Catalyst, Inc. (HCAT) trades at a FCF yield of 7.11% and a price-to-free-cash-flow ratio of 13.4x. FCF per share stands at $0.13, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

7.11%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.13

TTM FCF ÷ Shares Outstanding

Price / FCF

x13.4

Share Price ÷ FCF per Share

EV / FCF (TTM)

x9.6

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

HCAT · cash flow statement · operating / investing / financing

For FY2025, Health Catalyst, Inc. generated $0.7M in operating cash flow and spent 1M in capital expenditures, yielding −$0.2M in free cash flow.

Operating Activities

+$0.7M

Cash from core business operations

2025-12-31

Investing Activities

+$36.2M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$235.8M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($0.7M) − |CapEx| (1M) = FCF (−$0.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

HCAT vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Health Catalyst, Inc.YOU

HCAT

−$237,000+87.1%-0.1%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Health Catalyst, Inc. (HCAT) reported free cash flow of −$237,000 for FY2025 (fiscal year ending 2025-12-31), up 87.1% year-over-year. The FCF margin was -0.1%.

Health Catalyst, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 9 fiscal years.

Health Catalyst, Inc.'s FCF yield is 7.11% and price-to-FCF ratio is 13.4x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

HCAT free cash flow · 8 questions

Health Catalyst, Inc. free cash flow was −$237,000 for FY2025, up 87.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $9.2M.

HCAT free cash flowHCAT FCFHCAT FCF 2025HCAT free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Health Catalyst, Inc. · Health Catalyst, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026